Steroids Combined With Ruxolitinib as First-Line Therapy for Grade II Acute Graft-versus-Host Disease
Clinical trial NCT07576010 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07576010
- Sponsor
- Daihong Liu
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-17
- Primary completion
- 2027-12-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.